Corteva (NYSE:CTVA) Announces FY 2026 Earnings Guidance

Corteva (NYSE:CTVA – Get Free Report) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of 0.760-0.800 for the period, compared to the consensus earnings per share estimate of 1.070.

Corteva Stock Performance

Corteva stock opened at $12.20 on Thursday. The stock has a fifty day moving average price of $40.43 and a 200 day moving average price of $70.20. Corteva has a 52 week low of $11.24 and a 52 week high of $90.97. The firm has a market capitalization of $8.14 billion, a P/E ratio of 8.08, a PEG ratio of 1.70 and a beta of 0.58. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA – Get Free Report) last issued its quarterly earnings results on Wednesday, November 11th. The company reported $0.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.02 by $0.04. The firm had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.77 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%. The firm’s quarterly revenue was down 8.7% on a year-over-year basis. During the same period last year, the company earned ($0.23) EPS. Corteva has set its FY 2026 guidance at 0.760-0.800 EPS. Equities research analysts anticipate that Corteva will post 1.05 earnings per share for the current year.

Corteva Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Tuesday, December 1st will be issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 1.6%. The ex-dividend date is Tuesday, December 1st. This is a decrease from Corteva’s previous quarterly dividend of $0.18. Corteva’s payout ratio is currently 47.68%.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. UBS Group decreased their target price on shares of Corteva to $15.00 and set a “neutral” rating on the stock in a research report on Monday, October 12th. Argus reissued a “buy” rating and set a $91.00 price objective on shares of Corteva in a research note on Friday, September 18th. New Street Research set a $17.00 price objective on Corteva in a report on Monday, October 5th. Citigroup upped their price objective on Corteva from $86.00 to $91.00 and gave the stock a “neutral” rating in a report on Thursday, September 17th. Finally, Zacks Research lowered Corteva from a “hold” rating to a “strong sell” rating in a research report on Tuesday, October 6th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $60.59.

Read Our Latest Stock Report on Corteva

Corteva Company Profile

(Get Free Report)

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.

Read More

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.